236 related articles for article (PubMed ID: 9195570)
1. Cytokeratin subtyping in chordomas and the fetal notochord: an immunohistochemical analysis of aberrant expression.
Naka T; Iwamoto Y; Shinohara N; Chuman H; Fukui M; Tsuneyoshi M
Mod Pathol; 1997 Jun; 10(6):545-51. PubMed ID: 9195570
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of cytokeratins in the abnormal corneal endothelium of posterior polymorphous corneal dystrophy patients.
Jirsova K; Merjava S; Martincova R; Gwilliam R; Ebenezer ND; Liskova P; Filipec M
Exp Eye Res; 2007 Apr; 84(4):680-6. PubMed ID: 17289024
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin contents of basal cell carcinoma, epidermis overlying tumour, and associated stromal amyloidosis: an immunohistochemical study.
Apaydin R; Gürbüz Y; Bayramgürler D; Bilen N
Amyloid; 2005 Mar; 12(1):41-7. PubMed ID: 16076610
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical profiling of cytokeratin expression by endometrial stroma sarcoma.
Adegboyega PA; Qiu S
Hum Pathol; 2008 Oct; 39(10):1459-64. PubMed ID: 18619644
[TBL] [Abstract][Full Text] [Related]
5. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
Tirabosco R; Mangham DC; Rosenberg AE; Vujovic S; Bousdras K; Pizzolitto S; De Maglio G; den Bakker MA; Di Francesco L; Kalil RK; Athanasou NA; O'Donnell P; McCarthy EF; Flanagan AM
Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055
[TBL] [Abstract][Full Text] [Related]
6. [Expression of embryonal and differentiational proteins in chordomas and in the notochord].
Tamayama C; Miyauchi M; Maruyama K
Gan No Rinsho; 1990 Jan; 36(1):7-12. PubMed ID: 1688959
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
Stroescu C; Herlea V; Dragnea A; Popescu I
J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical distinction of classic and chondroid chordomas.
Walker WP; Landas SK; Bromley CM; Sturm MT
Mod Pathol; 1991 Sep; 4(5):661-6. PubMed ID: 1722044
[TBL] [Abstract][Full Text] [Related]
9. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of cytokeratins typical for columnar and squamous differentiation in sinonasal inverted papillomas.
Schwerer MJ; Kraft K; Baczako K; Maier H
Am J Clin Pathol; 2001 May; 115(5):747-54. PubMed ID: 11345840
[TBL] [Abstract][Full Text] [Related]
11. Parachordoma is not distinguishable from axial chordoma using immunohistochemistry.
Scolyer RA; Bonar SF; Palmer AA; Barr EM; Wills EJ; Stalley P; Schatz J; Soper J; Li LX; McCarthy SW
Pathol Int; 2004 May; 54(5):364-70. PubMed ID: 15086843
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin expression profiles in thyroid carcinomas.
Lam KY; Lui MC; Lo CY
Eur J Surg Oncol; 2001 Nov; 27(7):631-5. PubMed ID: 11669590
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
Ansai S; Arase S; Kawana S; Kimura T
J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and immunohistochemical study of 39 cases of Adenomatoid Odontogenic Tumour: a multicentric study.
Leon JE; Mata GM; Fregnani ER; Carlos-Bregni R; de Almeida OP; Mosqueda-Taylor A; Vargas PA
Oral Oncol; 2005 Sep; 41(8):835-42. PubMed ID: 15979930
[TBL] [Abstract][Full Text] [Related]
16. [Expression of cytokeratins in tumors with perineural differentiation].
Shelekhova KV; Danilova AB
Arkh Patol; 2009; 71(6):12-5. PubMed ID: 20131499
[TBL] [Abstract][Full Text] [Related]
17. Compensation of type I and type II cytokeratin pools in lung cancer.
Kanaji N; Bandoh S; Fujita J; Ishii T; Ishida T; Kubo A
Lung Cancer; 2007 Mar; 55(3):295-302. PubMed ID: 17161499
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin expression in lichen amyloidosus and macular amyloidosis.
Apaydin R; Gürbüz Y; Bayramgürler D; Müezzinoglu B; Bilen N
J Eur Acad Dermatol Venereol; 2004 May; 18(3):305-9. PubMed ID: 15096140
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors.
Ferrero M; Spyratos F; Le Doussal V; Desplaces A; Rouëssé J
Cytometry; 1990; 11(6):716-24. PubMed ID: 1696538
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
